"UMass Memorial Medical Center is the region's trusted academic medical center, part of the UMass Memorial Health Care system. We are committed to improving the health of people in Central Massachusetts through excellence in care, comprehensive health services, teaching and research."

During the past decade, Umass Memorial Medical Center- Memorial Campus conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Umass Memorial Medical Center- Memorial Campus" #1 sponsor was "Pfizer" with 2 trials, followed by "Ampel BioSolutions, LLC" with 1 trials sponsored, "Galapagos NV" with 1 trials sponsored, "Gynecologic Oncology Group" with 1 trials sponsored and "Karim Alavi" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Umass Memorial Medical Center- Memorial Campus" #1 collaborator was "Gilead Sciences" with 1 trials as a collaborator and "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Umass Memorial Medical Center- Memorial Campus" are "Rheumatoid Arthritis" (2 trials), "Arthritis, Rheumatoid" (1 trials), "Colovesical Fistula" (1 trials), "Endometrial Cancer" (1 trials) and "Esophageal Cancer" (1 trials). Many other conditions were trialed in "Umass Memorial Medical Center- Memorial Campus" in a lesser frequency.

Most popular intervention types in "Umass Memorial Medical Center- Memorial Campus" are "Drug" (5 trials), "Biological" (3 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "paclitaxel" (2 trials), "Filgotinib" (1 trials), "MabThera" (1 trials), "PF-05280586" (1 trials) and "Placebo to match filgotinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Umass Memorial Medical Center- Memorial Campus" are 7 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Umass Memorial Medical Center- Memorial Campus". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Umass Memorial Medical Center- Memorial Campus, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Umass Memorial Medical Center- Memorial Campus, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".